Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/14/2003EP0672141B1 Methods of preparing soluble, oligomeric proteins
05/14/2003EP0550450B1 Use of crosslinked crystals as a novel form of enzyme immobilization
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418251A Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use
05/14/2003CN1418222A Novel peptide and screening method by using the same
05/14/2003CN1417344A Technological process of extracting rice protein from distiller's grains
05/14/2003CN1417231A Prepn of recombinant human parathyroid hormone PTH (1-34)
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003US6562951 Method of solubilization and naturation of somatotropins
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562622 Continuous in vitro evolution
05/13/2003US6562618 Monoclonal antibody for use in the treatment of connective tissue, cancers, arteriosclerotic, skin and kidney disorders
05/13/2003US6562599 Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B containing these
05/13/2003US6562598 Factor X deletion mutants and analogues thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562591 Cell cycle protein for use in the diagnosis and tratment of cancer and cell proliferative disorders
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562588 Sialidase and recombinant cell lines
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562580 Detection of preferential binding protein; obtain kinase protein, incubate with potential binding protein, monitor activity of kinase, adjustment in activity indicates bound protein
05/13/2003US6562579 Diagnosing autoimmune disease; obtain sample, incubate with antibody, determine the concentration of preferential cytokine protein in sample, comparing to control, adjustment in cytokine concentration indicates autoimmune disease
05/13/2003US6562563 Detection of modulator of mitochondrial permeability transition; obtain cell containing mitochondrion, incubate with modulator, exposing cell to excitation energy, detect energy transfer, compare to control
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562341 Antibodies specific for native PrPSc
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003CA2467719A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/13/2003CA2086131C Anti-human ige monoclonal antibodies
05/08/2003WO2003038443A2 Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038082A2 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037921A1 Immunointeractive molecules and uses thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037370A2 Anthrax antigenic compositions
05/08/2003WO2003037364A1 Interleukin-18 inducing agent
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003006649A3 Expression system
05/08/2003WO2002098368A3 Mutant forms of cholera holotoxin as an adjuvant
05/08/2003WO2002088168A3 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
05/08/2003WO2002072847A3 Process for production of polypeptides
05/08/2003WO2002064773A3 Method for high throughput screening of candidate compounds by high throughput direct synthesis of recombinant polypeptides
05/08/2003WO2002057226A3 68730 and 69112 protein kinase molecules and uses therefor
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088890 Novel ecdysone receptors and methods for their use
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030088072 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030088064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030088063 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087395 Nucleotide sequences coding polypepide for use in the treatment of cardiovascular and immunological disorders
05/08/2003US20030087394 Nucleotides equences coding polypeptide for use in the treatment of pancreatic disorders
05/08/2003US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis
05/08/2003US20030087385 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of tumor and cell proliferation disorders
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030087382 25501, a human transferase family member and uses therefor
05/08/2003US20030087380 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological disorders
05/08/2003US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
05/08/2003US20030087378 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087377 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087376 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of tumor and cell proliferation disorders
05/08/2003US20030087375 Sperm specific proteins
05/08/2003US20030087372 Methods of culturing animal cells and polypeptide production in animal cells
05/08/2003US20030087371 Modulatory proteins of human CNS receptors
05/08/2003US20030087370 Novel nucleic acids and polypeptides
05/08/2003US20030087369 Granule-bound starch synthase
05/08/2003US20030087368 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
05/08/2003US20030087367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087366 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087365 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087364 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087360 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087359 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087358 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087356 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087355 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087354 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 1125